Comparative proteomics, genomics and pulmonary toxicity of instilled single walled carbon nanotubes, crocidolite asbestos and ultrafine carbon black in mice.
CNT have emerged as a nanomaterial of considerable concern to the occupational and environmental health and safety communities. Early, consistent reports from high-dose, short-term screening studies in rodents suggest a sequence of biological events and pulmonary pathology similar to that caused by asbestos and synthetic vitreous fibers (SVF). Whether CNT strictly adhere to the asbestos paradigm of pulmonary toxicity is a question of critical importance. The pulmonary response of mice exposed repeatedly (4 doses, 28 days, pharyngeal aspiration) to single-walled CNT (SWCNT), crocidolite asbestos (AS) and ultrafine carbon black (CB) was assessed by global proteomics and genomics of lung tissue and ELISA protein microarray of bronchial lavage fluid. Three cytokines, IL-6 and IL-12 and Mip-1g were considerably higher in SWCNT and AS treated animals compared to CB. The T cell chemotactic protein MDC was present in high levels in SWCNT and AS groups, but not detectable in control or CB treated groups. Two sentences on similarities and differences via proteomics. Microarray analysis of lung tissue revealed over 3000 genes significantly changed by SWCNT exposure, compared to only 469 with AS and 71 with CB. Strikingly, the significant genes lists for CB and AS were complete subsets of the SWCNT data set, with both the number of genes and magnitude of gene changes being the highest in the SWCNT treatment group.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.